AzTrials
AzTrials

Chronic PainNCT03493308

Pain Neuroscience Education and Exercise in Institutionalized Older Adults With Pain

A study testing Pain neuroscience education and Exercise in people with Chronic Pain, run by Aveiro University at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objectives of this study are to: Evaluate recruitment procedures and adherence rates; Evaluate the ability to understand the concepts of pain neurophysiology; Evaluate the acceptability of an intervention program based on pain neuroscience education and exercise by institutionalized older adults and the… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Chronic Pain
What is being tested?
Pain neuroscience education and Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
1 sitePortugal
Study dates
12 Apr 2018to 31 Aug 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Be institutionalized in any type of response (nursing home, day care, ...), be able to read and write, have chronic pain (defined as pain lasting 3 months or more and felt at least once a week during these 3 months ) anywhere in the body, and have a statement from the institution's physician authorizing participation in the exercise sessions.

Who cannot join

  • Have any contra-indication to exercise and have cognitive limitations (evaluated through the Montreal Cognitive Assessment questionnaire).

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Lar de Fermentelos

    Águeda Municipality

Other trials in Portugal

About this study

Official title: Pain Neuroscience Education and Exercise in Institutionalized Older Adults With Pain: A Feasibility Study

The primary objectives of this study are to:

  • Evaluate recruitment procedures and adherence rates;
  • Evaluate the ability to understand the concepts of pain neurophysiology;
  • Evaluate the acceptability of an intervention program based on pain neuroscience education and exercise by institutionalized older adults and the institutions where they are.
Read the detailed description

Participants will be older adults with pain that are institutionalized and assess the feasibility of implementing an intervention consisting of pain neuroscience education in addition to exercise. It is antecipated that the intervention will consist of 1 to 2 sessions per week during 8 weeks and will be delivered in small groups. Participants will be assessed for pain intensity, duration, catastrophizing, fear of movement, knowledge of pain neuroscience, depression and performance.

Conditions
Chronic Pain
Being tested
Pain neuroscience education, Exercise
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pain neuroscience educationOther

    PNE will be conducted in line with international guidelines and will cover the neurophysiology of pain, transition from acute to chronic pain and the nervous system ability to modulate the pain experience.

  • ExerciseOther

    Exercise will be provided in different formats including general exercise, strengthening, dance.

Study groups in NCT03493308
Study groupRoleWhat they receive
Pain neuroscience and exerciseExperimentalParticipants will received an 8 week intervention consisting of pain neuroscience education and exercise. Pain neuroscience education will be conducted in line with international guidelines, covering the neurophysiology of pain, transition from from acute to chronic pain and the nervous system ability to modulate the pain experience. exercise will include general exercise and dance.
Receives: Other: Pain neuroscience education; Other: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Assessed using the vertical numeric rating scale that assesses pain intensity (range 0-10 and higher values are indicative of higher pain intensity)

    Measured: Baseline

  2. Pain intensity

    Assessed using the vertical numeric rating scale that assesses pain intensity (range 0-10 and higher values are indicative of higher pain intensity)

    Measured: 9 weeks

  3. Pain intensity

    Assessed using the vertical numeric rating scale that assesses pain intensity (range 0-10 and higher values are indicative of higher pain intensity)

    Measured: 3 months

Secondary outcomes (24)
  1. Pain location

    Assessed using a body chart where the patients identifies the painful body segments

    Measured: Baseline

  2. Pain location

    Assessed using a body chart where the patients identifies the painful body segments

    Measured: 9 weeks

  3. Pain location

    Assessed using a body chart where the patients identifies the painful body segments

    Measured: 3 months

  4. Pain frequency

    Assessed using a closed question on pain frequency for the last week

    Measured: Baseline

  5. Pain frequency

    Assessed using a closed question on pain frequency for the last week

    Measured: 9 weeks

  6. Pain frequency

    Assessed using a closed question on pain frequency for the last week

    Measured: 3 months

  7. Depression

    Assessed using the Geriatric Depression Scale (range 0-15 and values of 5 or higher are indicative of depression)

    Measured: Baseline

  8. Depression

    Assessed using the Geriatric Depression Scale (range 0-15 and values of 5 or higher are indicative of depression)

    Measured: 9 weeks

  9. Depression

    Assessed using the Geriatric Depression Scale (range 0-15 and values of 5 or higher are indicative of depression)

    Measured: 3 months

  10. Knowledge of pain neuroscience

    Assessed using the pain neurophysiology questionnaire

    Measured: Baseline

  11. Knowledge of pain neuroscience

    Assessed using the pain neurophysiology questionnaire (range 0-19 and higher values are indicative of more knowledge on pain neurophysiology)

    Measured: 9 weeks

  12. Knowledge of pain neuroscience

    Assessed using the pain neurophysiology questionnaire (range 0-19 and higher values are indicative of more knowledge on pain neurophysiology)

    Measured: 3 months

  13. Pain catastrophizing

    assessed using the Pain Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)

    Measured: Baseline

  14. Pain catastrophizing

    assessed using the Pain Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)

    Measured: 9 weeks

  15. Pain catastrophizing

    assessed using the Pain Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)

    Measured: 3 months

  16. Fear of movement

    Assessed using the TAMPA Scale, which assesses fear of movement (range: 13-52 and higher values are indicative of higher levels of fear of movement)

    Measured: Baseline

  17. Fear of movement

    Assessed using the TAMPA Scale (range: 13-52 and higher values are indicative of higher levels of fear of movement)

    Measured: 9 weeks

  18. Fear of movement

    Assessed using the TAMPA Scale (range: 13-52 and higher values are indicative of higher levels of fear of movement)

    Measured: 3 months

  19. Gait velocity

    Assessed using the gait velocity test - the time, in seconds, that each participant takes to walk 4 meters

    Measured: Baseline

  20. Gait velocity

    Assessed using the gait velocity test - the time, in seconds, that each participant takes to walk 4 meters

    Measured: 9 weeks

  21. Gait velocity

    Assessed using the gait velocity test - the time, in seconds, that each participant takes to walk 4 meters

    Measured: 3 months

  22. Postural control

    Assessed using the Timed up and go test - the time, in seconds, that it takes to stand from a chair, walk 3 meters, turn, walk another 3 meters to sit in the chair.

    Measured: Baseline

  23. Postural control

    Assessed using the Timed up and go test - the time, in seconds, that it takes to stand from a chair, walk 3 meters, turn, walk another 3 meters to sit in the chair.

    Measured: 9 weeks

  24. Postural control

    Assessed using the Timed up and go test - the time, in seconds, that it takes to stand from a chair, walk 3 meters, turn, walk another 3 meters to sit in the chair.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2018
  2. Study start12 Apr 2018
  3. Primary completion31 Aug 2018
  4. Study completion31 Aug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03493308
Sponsor's protocol ID
09-CED/2018
Status last verified
Sep 2018
First submitted
4 Apr 2018
Last updated
11 Sep 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Pain neuroscience education and Exercise in people with Chronic Pain, run by Aveiro University at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in